Last reviewed · How we verify

NCT03342885: SLEEPLBP

Sleep Ergonomics in Low Back Pain

Status unknown NA Last updated 17 November 2017
What this trial tests

NA trial testing Specific sleep ergonomics guidance in Low Back Pain in 120 participants. Status unknown.

Timeline
3 October 2017
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorCentral Finland Hospital District
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment120
Start date3 October 2017
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across Finland

Drugs / interventions tested

Conditions studied

Sponsor

Central Finland Hospital District

Who can join

18 and older, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of sleep ergonomics guidance given by physiotherapist on pain and disability in patients with low back pain. In this randomized controlled trial participants are assigned either into the intervention or the control group. The intervention group will receive detailed instruction on sleeping ergonomics whereas the control group will only be instructed to avoid painful sleeping posture. The initial hypothesis is that in the intervention group pain and disability will decrease more compared to the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Central Finland Hospital District trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03342885.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing